https://www.cnbc.com/2020/07/07/us-government-awards-novavax-1point6-billion-for-coronavirus-vaccine.html
- The U.S. government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States.
- The company aims to deliver 100 million doses by January 2021.
- The award is the biggest yet from “Operation Warp Speed,” the White House program aimed at accelerating access to vaccines and treatments to fight the coronavirus that causes Covid-19.